Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015', http://bit.ly/29QFXPp


In this issue


Home Eurosurveillance Edition  2011: Volume 16/ Issue 12 Article 6
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 16, Issue 12, 24 March 2011
News
Launch of free online database of international TB vaccination policies: the BCG World Atlas
  1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Citation style for this article: Eurosurveillance editorial team. Launch of free online database of international TB vaccination policies: the BCG World Atlas. Euro Surveill. 2011;16(12):pii=19823. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19823

A team of researchers from McGill University and the Research Institute of the McGill University Health Centre in Canada created an interactive website that provides free detailed information on current and past tuberculosis (TB) vaccination policies and practices for more than 180 countries: the BCG World Atlas [1].

The Atlas is intended to be a useful resource for clinicians, policymakers, and researchers and provides information that may be helpful for better interpretation of TB diagnostics as well as design of new TB vaccines [2]. The Bacille Calmette-Guérin (BCG) vaccine was introduced in 1921 and continues to be the only vaccine used to prevent TB. Clinicians need to be aware of the various BCG policies in different parts of the world, as well as of the changes made to those policies over time.

This project began in 2007 with the compilation of detailed information on past and present BCG vaccination policies on as many countries as possible. Data were assembled through questionnaires, published papers, reports, government policy documents and information available from the World Health Organization Vaccine Preventable Diseases Monitoring System [3]. Based on the data generated by all methods, countries were grouped into three main categories: (i) the country currently recommends universal BCG vaccination at a certain age; (ii) the country used to recommend universal BCG vaccination but currently does not; (iii) BCG vaccination is recommended only for selected high-risk groups or was never recommended.


References

  1. The BCG World Atlas [Internet]. [Accessed 23 Mar 2011]. Available from: http://www.bcgatlas.org/index.php
  2. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PloS Med. 2011;8(3):e1001012.
  3. World Health Organization (WHO). WHO Vaccine Preventable Diseases Monitoring System. Immunization schedules by antigen, selection centre. Geneva:WHO. 15 Dec 2010. Available from: http://apps.who.int/immunization_monitoring/en/globalsummary/scheduleselect.cfm


Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.